Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia (Q73699658)
Jump to navigation
Jump to search
scientific article published on 01 January 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia |
scientific article published on 01 January 2001 |
Statements
Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia (English)
Jándula BM
Marín P